Sbi Securities Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3,320 shares of LXRX stock, worth $3,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,320
Previous 3,064
8.36%
Holding current value
$3,386
Previous $2.26 Million
32.39%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
134Shares Held
199MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$139 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$9.75 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$8.38 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$3.76 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $193M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...